Risk management
Risk management
Risk management
Draft guideline on VICH GL60 Good manufacturing practice for active ingredients used in veterinary medicinal products
Paediatric medicines: Marketing authorisation
Medicines for use outside the European Union
VICH GL60 Good manufacturing practice for active ingredients used in veterinary medicinal products - Scientific guideline
FAQs: How to create, submit and withdraw a Clinical Trial Application - CTIS Training Programme - Module 10
Clinical Trial Information System (CTIS) - Sponsor handbook
Hycamtin (topotecan) supply shortage
Withdrawn application: Lutholaz, Date of withdrawal: 19/07/2023, Initial authorisation
Human medicines European public assessment report (EPAR): Rebetol, ribavirin, Hepatitis C, Chronic, Date of authorisation: 06/05/1999, Revision: 39, Status: Withdrawn